[Prolactin receptors and breast cancer].
A study has been carried out on 116 mammary neoplasias in which the prolactin receptors together with other clinical and hormonal parameters have been determined. A 46.3% frequency of PRLR+ has been obtained as well as a statistically significant correlation between these and blood estradiol (p less than 0.05). PRLR- have greater survival and PRLR may act as a growth factor.
Basilio
E
E
Hospital Clínico de Barcelona, España.
Prats
M
M
Rivera
F
F
D001943:Breast Neoplasms / Q000032:analysis* / Q000503:physiopathology; D003687:Dehydroepiandrosterone / Q000097:blood; D004958:Estradiol / Q000097:blood; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000032:analysis* / Q000503:physiopathology; D011374:Progesterone / Q000097:blood; D011379:Prognosis; D011388:Prolactin / Q000097:blood; D011981:Receptors, Prolactin / Q000032:analysis / Q000502:physiology*
D011981:Receptors, Prolactin; D003687:Dehydroepiandrosterone; D011374:Progesterone; D004958:Estradiol; D011388:Prolactin
Receptores de prolactina y cáncer de mama.